{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:48:20Z","timestamp":1790617700975,"version":"4.1.0"},"reference-count":74,"publisher":"American Society of Hematology","issue":"16","license":[{"start":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:00:00Z","timestamp":1719964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8,27]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Mantle cell lymphoma (MCL) is dependent on a supportive tumor immune microenvironment (TIME) in which infiltration of CD163+ macrophages has a negative prognostic impact. This study explores how abundance and spatial localization of CD163+ cells are associated with the biology of MCL, using spatial multiomic investigations of tumor and infiltrating CD163+ and CD3+ cells. A total of 63 proteins were measured using GeoMx digital spatial profiling in tissue microarrays from 100 diagnostic MCL tissues. Regions of interest were selected in tumor-rich and tumor-sparse tissue regions. Molecular profiling of CD163+ macrophages, CD20+ MCL cells, and CD3+ T-cells was performed. To validate protein profiles, 1811 messenger RNAs were measured in CD20+ cells and 2 subsets of T cells. Image\u00a0analysis was used to extract the phenotype and position of each targeted cell, thereby allowing the exploration of cell frequencies and cellular neighborhoods. Proteomic investigations revealed that CD163+ cells modulate their immune profile depending on their localization and that the immune inhibitory molecules, V-domain immunoglobulin suppressor of T-cell activation and B7 homolog 3, have higher expression in tumor-sparse than in tumor-rich tissue regions and that targeting should be explored. We showed that MCL tissues with more abundant infiltration of CD163+ cells have a higher proteomic and transcriptional expression of key components of the MAPK pathway. Thus, the MAPK pathway may be a feasible therapeutic target in patients with MCL with CD163+ cell infiltration. We further showed the independent and combined prognostic values of CD11c and CD163 beyond established risk factors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2023012039","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T14:45:44Z","timestamp":1720017944000},"page":"4370-4385","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":8,"title":["CD163+ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression"],"prefix":"10.1182","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1806-331X","authenticated-orcid":false,"given":"Joana","family":"de Matos Rodrigues","sequence":"first","affiliation":[{"name":"1Department of Immunotechnology, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0045-8076","authenticated-orcid":false,"given":"Lavanya","family":"Lokhande","sequence":"additional","affiliation":[{"name":"1Department of Immunotechnology, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1359-0295","authenticated-orcid":false,"given":"Lina M.","family":"Olsson","sequence":"additional","affiliation":[{"name":"1Department of Immunotechnology, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Hassan","sequence":"additional","affiliation":[{"name":"1Department of Immunotechnology, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Johansson","sequence":"additional","affiliation":[{"name":"1Department of Immunotechnology, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Jansk\u00e1","sequence":"additional","affiliation":[{"name":"1Department of Immunotechnology, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5371-1779","authenticated-orcid":false,"given":"Darshan","family":"Kumar","sequence":"additional","affiliation":[{"name":"2Aiforia Technologies Plc, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Schmidt","sequence":"additional","affiliation":[{"name":"1Department of Immunotechnology, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1451-0699","authenticated-orcid":false,"given":"Anna","family":"Nikkarinen","sequence":"additional","affiliation":[{"name":"3Department of Immunology, Genetics and Pathology, Cancer Precision Medicine, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0226-5681","authenticated-orcid":false,"given":"Peter","family":"Hollander","sequence":"additional","affiliation":[{"name":"4Department of Immunology, Genetics and Pathology, Clinical and Experimental Pathology, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6158-3041","authenticated-orcid":false,"given":"Ingrid","family":"Glimelius","sequence":"additional","affiliation":[{"name":"3Department of Immunology, Genetics and Pathology, Cancer Precision Medicine, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Porwit","sequence":"additional","affiliation":[{"name":"5Division of Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1932-0365","authenticated-orcid":false,"given":"Anna Sandstrom","family":"Gerdtsson","sequence":"additional","affiliation":[{"name":"1Department of Immunotechnology, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Jerkeman","sequence":"additional","affiliation":[{"name":"6Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1388-4912","authenticated-orcid":false,"given":"Sara","family":"Ek","sequence":"additional","affiliation":[{"name":"1Department of Immunotechnology, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,8,16]]},"reference":[{"key":"2024082712512342600_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.anndiagpath.2018.09.014","article-title":"Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues","volume":"38","author":"Grimm","year":"2019","journal-title":"Ann Diagn Pathol"},{"issue":"suppl_4","key":"2024082712512342600_bib2","doi-asserted-by":"crossref","first-page":"iv62","DOI":"10.1093\/annonc\/mdx223","article-title":"Newly diagnosed and relapsed mantle cell lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Dreyling","year":"2017","journal-title":"Ann Oncol"},{"issue":"6","key":"2024082712512342600_bib3","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ajh.25487","article-title":"Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management","volume":"94","author":"Jain","year":"2019","journal-title":"Am J Hematol"},{"issue":"3","key":"2024082712512342600_bib4","doi-asserted-by":"crossref","first-page":"e153283","DOI":"10.1172\/JCI153283","article-title":"Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma","volume":"132","author":"Yi","year":"2022","journal-title":"J\u00a0Clin Invest"},{"issue":"suppl 1","key":"2024082712512342600_bib5","first-page":"1","article-title":"Efficacy and safety of ibrutinib combined with standard first-line treatment or as substitute for autologous stem cell transplantation in younger patients with mantle cell lymphoma: results from the randomized triangle trial by the European MCL Network","volume":"140","author":"Dreyling JKD","year":"2022","journal-title":"American society of hematology"},{"issue":"17","key":"2024082712512342600_bib6","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood-2017-04-779736","article-title":"TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy","volume":"130","author":"Eskelund","year":"2017","journal-title":"Blood"},{"issue":"1","key":"2024082712512342600_bib7","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1097\/HS9.0000000000000510","article-title":"Detailed long-term follow-up of patients who relapsed after the Nordic mantle cell lymphoma trials: MCL2 and MCL3","volume":"5","author":"Eskelund","year":"2021","journal-title":"Hemasphere"},{"issue":"19","key":"2024082712512342600_bib8","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1182\/blood-2008-10-185827","article-title":"Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting","volume":"113","author":"Kurtova","year":"2009","journal-title":"Blood"},{"issue":"14","key":"2024082712512342600_bib9","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1182\/bloodadvances.2020003871","article-title":"Mantle cell lymphoma polarizes tumor-associated macrophages into M2-like macrophages, which in turn promote tumorigenesis","volume":"5","author":"Le","year":"2021","journal-title":"Blood Adv"},{"issue":"5","key":"2024082712512342600_bib10","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1080\/10428194.2017.1357177","article-title":"Rationale for targeting tumor cells in their microenvironment for mantle cell lymphoma treatment","volume":"59","author":"Papin","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"2024082712512342600_bib11","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1038\/s41375-019-0463-3","article-title":"CSF1R and BTK inhibitions as novel strategies to disrupt the dialog between mantle cell lymphoma and macrophages","volume":"33","author":"Papin","year":"2019","journal-title":"Leukemia"},{"issue":"3","key":"2024082712512342600_bib12","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/bjh.17366","article-title":"Infiltration of CD163-PD-L1- and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors","volume":"193","author":"Rodrigues","year":"2021","journal-title":"Br J Haematol"},{"key":"2024082712512342600_bib13","doi-asserted-by":"crossref","first-page":"701492","DOI":"10.3389\/fonc.2021.701492","article-title":"High counts of CD68+ and CD163+ macrophages in mantle cell lymphoma are associated with inferior prognosis","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"key":"2024082712512342600_bib14","doi-asserted-by":"crossref","first-page":"642285","DOI":"10.3389\/fimmu.2021.642285","article-title":"Mechanisms of macrophage plasticity in the tumor environment: manipulating activation state to improve outcomes","volume":"12","author":"Ricketts","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"2024082712512342600_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41392-021-00506-6","article-title":"Targeting macrophages in cancer immunotherapy","volume":"6","author":"Duan","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"2024082712512342600_bib16","doi-asserted-by":"crossref","first-page":"1373269","DOI":"10.3389\/fimmu.2024.1373269","article-title":"Empowering macrophages: the cancer fighters within the tumour microenvironment in mantle cell lymphoma","volume":"15","author":"Nylund","year":"2024","journal-title":"Front Immunol"},{"issue":"18","key":"2024082712512342600_bib17","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.1182\/bloodadvances.2023010052","article-title":"Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy-treated mantle cell lymphoma","volume":"7","author":"Nikkarinen","year":"2023","journal-title":"Blood Adv"},{"issue":"3","key":"2024082712512342600_bib18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41587-019-0392-8","article-title":"Integrating microarray-based spatial transcriptomics and single-cell RNA-seq reveals tissue architecture in pancreatic ductal adenocarcinomas","volume":"38","author":"Moncada","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"16","key":"2024082712512342600_bib19","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1182\/bloodadvances.2022007493","article-title":"Single-cell spatial analysis of tumor immune architecture in diffuse large B-cell lymphoma","volume":"6","author":"Colombo","year":"2022","journal-title":"Blood Adv"},{"issue":"1","key":"2024082712512342600_bib20","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.1038\/s41467-021-26614-z","article-title":"Spatially resolved transcriptomics reveals the architecture of the tumor-microenvironment interface","volume":"12","author":"Hunter","year":"2021","journal-title":"Nat Commun"},{"issue":"7","key":"2024082712512342600_bib21","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nm0798-844","article-title":"Tissue microarrays for high-throughput molecular profiling of tumor specimens","volume":"4","author":"Kononen","year":"1998","journal-title":"Nat Med"},{"issue":"11","key":"2024082712512342600_bib22","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1080\/10428194.2021.1933480","article-title":"Targeted genomic investigations in a population-based cohort of mantle cell lymphoma reveal novel clinically relevant targets","volume":"62","author":"Rodrigues","year":"2021","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"2024082712512342600_bib23","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/bjh.17023","article-title":"p53 is associated with high-risk and pinpoints TP53 missense mutations in mantle cell lymphoma","volume":"191","author":"Rodrigues","year":"2020","journal-title":"Br J Haematol"},{"issue":"5","key":"2024082712512342600_bib24","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41587-020-0472-9","article-title":"Multiplex digital spatial profiling of proteins and RNA in fixed tissue","volume":"38","author":"Merritt","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"4","key":"2024082712512342600_bib25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/imm.13441","article-title":"Double-negative T cells: setting the stage for disease control or progression","volume":"165","author":"Velikkakam","year":"2022","journal-title":"Immunology"},{"issue":"4","key":"2024082712512342600_bib26","first-page":"1171","article-title":"MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53\/p53 - a Nordic Lymphoma Group study","volume":"109","author":"Rodrigues","year":"2024","journal-title":"Haematologica"},{"issue":"12","key":"2024082712512342600_bib27","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/s41592-022-01663-4","article-title":"Cellpose 2.0: how to train your own model","volume":"19","author":"Pachitariu","year":"2022","journal-title":"Nat Methods"},{"issue":"1","key":"2024082712512342600_bib28","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"issue":"18","key":"2024082712512342600_bib29","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"issue":"13","key":"2024082712512342600_bib30","first-page":"1","article-title":"lmerTest package: tests in linear mixed effects models","volume":"82","author":"Kuznetsova","year":"2017","journal-title":"J\u00a0Stat Softw"},{"issue":"3","key":"2024082712512342600_bib31","first-page":"100141","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"issue":"5","key":"2024082712512342600_bib32","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"issue":"4","key":"2024082712512342600_bib33","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.bpj.2009.05.039","article-title":"On the use of Ripley's K-function and its derivatives to analyze domain size","volume":"97","author":"Kiskowski","year":"2009","journal-title":"Biophys J"},{"key":"2024082712512342600_bib34","author":"Turner","year":"2015"},{"issue":"3","key":"2024082712512342600_bib35","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.it.2020.12.008","article-title":"VISTA: a mediator of quiescence and a promising target in cancer immunotherapy","volume":"42","author":"Yuan","year":"2021","journal-title":"Trends Immunol"},{"issue":"1","key":"2024082712512342600_bib36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13045-020-00917-y","article-title":"VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy","volume":"13","author":"Huang","year":"2020","journal-title":"J\u00a0Hematol Oncol"},{"issue":"12","key":"2024082712512342600_bib37","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1002\/ijc.28474","article-title":"B7-H3-mediated tumor immunology: friend or foe?","volume":"134","author":"Wang","year":"2014","journal-title":"Int J Cancer"},{"issue":"12","key":"2024082712512342600_bib38","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nri3921","article-title":"STING: infection, inflammation and cancer","volume":"15","author":"Barber","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2024082712512342600_bib39","doi-asserted-by":"crossref","first-page":"491","DOI":"10.4049\/jimmunol.1401214","article-title":"Granzymes regulate proinflammatory cytokine responses","volume":"194","author":"Wensink","year":"2015","journal-title":"J\u00a0Immunol"},{"issue":"14","key":"2024082712512342600_bib40","doi-asserted-by":"crossref","first-page":"dev176180","DOI":"10.1242\/dev.176180","article-title":"The lymphoid-associated interleukin 7 receptor (IL7R) regulates tissue-resident macrophage development","volume":"146","author":"Leung","year":"2019","journal-title":"Development"},{"issue":"3","key":"2024082712512342600_bib41","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nri2035","article-title":"MAPK phosphatases--regulating the immune response","volume":"7","author":"Liu","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"2024082712512342600_bib42","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/978-0-387-89520-8_11","article-title":"GITR: a modulator of immune response and inflammation","volume":"647","author":"Nocentini","year":"2009","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"2024082712512342600_bib43","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1006\/smim.1998.0157","article-title":"Role of 4-1BB in immune responses","volume":"10","author":"Vinay","year":"1998","journal-title":"Semin Immunol"},{"issue":"1","key":"2024082712512342600_bib44","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13045-018-0644-y","article-title":"Targeting the IDO1 pathway in cancer: from bench to bedside","volume":"11","author":"Liu","year":"2018","journal-title":"J\u00a0Hematol Oncol"},{"issue":"2","key":"2024082712512342600_bib45","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1309\/AJCPOGCI3DAXVUMI","article-title":"The role of CD11c expression in the diagnosis of mantle cell lymphoma","volume":"134","author":"Kraus","year":"2010","journal-title":"Am J Clin Pathol"},{"issue":"16","key":"2024082712512342600_bib46","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1182\/bloodadvances.2023009813","article-title":"Diffuse large B-cell lymphomas have spatially defined, tumor immune microenvironments revealed by high-parameter imaging","volume":"7","author":"Wright","year":"2023","journal-title":"Blood Adv"},{"issue":"8","key":"2024082712512342600_bib47","doi-asserted-by":"crossref","first-page":"e71189","DOI":"10.1371\/journal.pone.0071189","article-title":"Intratumoral alpha-SMA enhances the prognostic potency of CD34 associated with maintenance of microvessel integrity in hepatocellular carcinoma and pancreatic cancer","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"2024082712512342600_bib48","doi-asserted-by":"crossref","first-page":"100744","DOI":"10.1016\/j.tranon.2020.100744","article-title":"Inflammatory infiltrate and angiogenesis in mantle cell lymphoma","volume":"13","author":"Annese","year":"2020","journal-title":"Transl Oncol"},{"issue":"23","key":"2024082712512342600_bib49","doi-asserted-by":"crossref","first-page":"6096","DOI":"10.1158\/1078-0432.CCR-14-0889","article-title":"T-cell levels are prognostic in mantle cell lymphoma","volume":"20","author":"Nygren","year":"2014","journal-title":"Clin Cancer Res"},{"key":"2024082712512342600_bib50","doi-asserted-by":"crossref","first-page":"837645","DOI":"10.3389\/fimmu.2022.837645","article-title":"The role of immune checkpoint molecules on macrophages in cancer, infection, and autoimmune pathologies","volume":"13","author":"Brom","year":"2022","journal-title":"Front Immunol"},{"issue":"5","key":"2024082712512342600_bib51","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1073\/pnas.1811067116","article-title":"Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer","volume":"116","author":"Blando","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2024082712512342600_bib52","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1038\/s41467-020-17670-y","article-title":"A\u00a0decade of immune-checkpoint inhibitors in cancer therapy","volume":"11","author":"Robert","year":"2020","journal-title":"Nat Commun"},{"issue":"4","key":"2024082712512342600_bib53","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41416-018-0188-5","article-title":"STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer","volume":"119","author":"Ghaffari","year":"2018","journal-title":"Br J Cancer"},{"issue":"1","key":"2024082712512342600_bib54","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12943-019-1087-y","article-title":"STING: a master regulator in the cancer-immunity cycle","volume":"18","author":"Zhu","year":"2019","journal-title":"Mol Cancer"},{"issue":"11","key":"2024082712512342600_bib55","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.3390\/cancers13112695","article-title":"STING agonists as cancer therapeutics","volume":"13","author":"Amouzegar","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"54","key":"2024082712512342600_bib56","doi-asserted-by":"crossref","first-page":"93156","DOI":"10.18632\/oncotarget.21114","article-title":"Prognostic value of B7-H3 expression in patients with solid tumors: a meta-analysis","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"2024082712512342600_bib57","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.bbrc.2018.12.055","article-title":"MicroRNA-506 inhibits the proliferation and invasion of mantle cell lymphoma cells by targeting B7H3","volume":"508","author":"Zhu","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"2024082712512342600_bib58","doi-asserted-by":"crossref","first-page":"114298","DOI":"10.1016\/j.bcp.2020.114298","article-title":"B7-H3 augments the pro-angiogenic function of tumor-associated macrophages and acts as a novel adjuvant target for triple-negative breast cancer therapy","volume":"183","author":"Cheng","year":"2021","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"2024082712512342600_bib59","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5483\/BMBRep.2014.47.3.283","article-title":"4-1BB (CD137), an inducible costimulatory receptor, as a specific target for cancer therapy","volume":"47","author":"Vinay","year":"2014","journal-title":"BMB Rep"},{"issue":"8","key":"2024082712512342600_bib60","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.3324\/haematol.2017.184192","article-title":"Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy","volume":"103","author":"de Charette","year":"2018","journal-title":"Haematologica"},{"issue":"21","key":"2024082712512342600_bib61","doi-asserted-by":"crossref","first-page":"e19883","DOI":"10.1097\/MD.0000000000019883","article-title":"IDO, TDO, and AHR overexpression is associated with poor outcome in diffuse large B-cell lymphoma patients in the rituximab era","volume":"99","author":"Chen","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"2024082712512342600_bib62","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/1471-2407-14-335","article-title":"Indoleamine 2,3-dioxygenase (IDO) is frequently expressed in stromal cells of Hodgkin lymphoma and is associated with adverse clinical features: a retrospective cohort study","volume":"14","author":"Choe","year":"2014","journal-title":"BMC Cancer"},{"issue":"1-2","key":"2024082712512342600_bib63","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cellimm.2014.02.005","article-title":"The role of indoleamine 2,3-dioxygenase (IDO) in immune tolerance: focus on macrophage polarization of THP-1 cells","volume":"289","author":"Wang","year":"2014","journal-title":"Cell Immunol"},{"issue":"4","key":"2024082712512342600_bib64","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood-2017-04-776740","article-title":"SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma","volume":"130","author":"Balsas","year":"2017","journal-title":"Blood"},{"issue":"5","key":"2024082712512342600_bib65","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1182\/blood-2006-04-015586","article-title":"Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma","volume":"108","author":"Rudelius","year":"2006","journal-title":"Blood"},{"key":"2024082712512342600_bib66","doi-asserted-by":"crossref","first-page":"692320","DOI":"10.3389\/fcell.2021.692320","article-title":"Role of the bone marrow niche in supporting the pathogenesis of lymphoid malignancies","volume":"9","author":"Jalali","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"12","key":"2024082712512342600_bib67","doi-asserted-by":"crossref","first-page":"14350","DOI":"10.18632\/oncotarget.7320","article-title":"Hedgehog inhibitors selectively target cell migration and adhesion of mantle cell lymphoma in bone marrow microenvironment","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"2024082712512342600_bib68","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/ph13010009","article-title":"Mitogen-activated protein kinase inhibitors and T-cell-dependent immunotherapy in cancer","volume":"13","author":"Kumar","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"issue":"8","key":"2024082712512342600_bib69","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3324\/haematol.2011.040659","article-title":"Mesenchymal stromal cells protect mantle cell lymphoma cells from spontaneous and drug-induced apoptosis through secretion of B-cell activating factor and activation of the canonical and non-canonical nuclear factor \u03baB pathways","volume":"97","author":"Medina","year":"2012","journal-title":"Haematologica"},{"issue":"1","key":"2024082712512342600_bib70","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1158\/1078-0432.CCR-15-0987","article-title":"ROS-induced CXCR4 signaling regulates mantle cell lymphoma (MCL) cell survival and drug resistance in the bone marrow microenvironment via autophagy","volume":"22","author":"Chen","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2024082712512342600_bib71","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1182\/blood-2016-05-718494","article-title":"Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling","volume":"129","author":"Myklebust","year":"2017","journal-title":"Blood"},{"issue":"2","key":"2024082712512342600_bib72","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/JMAU.JMAU_68_18","article-title":"Mitogen-activated protein kinase pathway: a critical regulator in tumor-associated macrophage polarization","volume":"7","author":"Neamatallah","year":"2019","journal-title":"J\u00a0Microsc Ultrastruct"},{"issue":"4","key":"2024082712512342600_bib73","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.4049\/jimmunol.176.4.2219","article-title":"The JNK are important for development and survival of macrophages","volume":"176","author":"Himes","year":"2006","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"2024082712512342600_bib74","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1165\/rcmb.2006-0165OC","article-title":"The role of the NADPH oxidase complex, p38 MAPK, and Akt in regulating human monocyte\/macrophage survival","volume":"36","author":"Wang","year":"2007","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/16\/4370\/2239762\/blooda_adv-2023-012039-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/16\/4370\/2239762\/blooda_adv-2023-012039-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T08:52:09Z","timestamp":1724748729000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/16\/4370\/516836\/CD163-macrophages-in-mantle-cell-lymphoma-induce"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,16]]},"references-count":74,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2024,8,27]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023012039","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,16]]}}}